Irritable Bowel Syndrome Stocks List

Recent Signals

Date Stock Signal Type
2021-02-25 ABT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 ARDX Expansion Pivot Sell Setup Bearish Swing Setup
2021-02-25 IRWD Lower Bollinger Band Walk Weakness
2021-02-25 LXRX Spinning Top Other

Recent News for Irritable Bowel Syndrome Stocks

Date Stock Title
Feb 26 ARDX Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Feb 26 ABT Why Is Abbott (ABT) Up 1% Since Last Earnings Report?
Feb 26 ABT Teleflex (TFX) Beats on Q4 Earnings and Revenues, Margins Fall
Feb 26 ABT Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates
Feb 26 ABT LHC Group (LHCG) Q4 Earnings Beat Estimates, Revenues Miss
Feb 26 ABT Allscripts (MDRX) Q4 Earnings and Revenues Beat Estimates
Feb 26 ABT NuVasive's (NUVA) Q4 Earnings Top Estimates, Margin Declines
Feb 26 BHC Bausch Health to further reduce debt by $100M
Feb 25 ABT Abbott (ABT) Stock Moves -0.65%: What You Should Know
Feb 25 BHC Matthew Keezer on Cruising During Travel Restrictions
Feb 25 BHC Bausch Health Companies Inc. (BHC) FY 2020 Earnings Call Transcript
Feb 24 BHC Bausch Health Companies Inc. (BHC) CEO Joe Papa on Q4 2020 Results - Earnings Call Transcript
Feb 24 BHC Bausch Health Adds 2 Directors Chosen By Carl Icahn: What Investors Need To Know
Feb 24 ABT Abbott Laboratories Is Priced For Perfection
Feb 24 ABT Top 15 Pharmaceutical Companies With Highest R&D Spending
Feb 24 BHC Recap: Bausch Health Q4 Earnings
Feb 24 BHC Under eye of Icahn, Bausch Health gives activist investor two board seats
Feb 24 BHC The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Feb 24 BHC Bausch Health reports narrower loss as revenue tops expectations, stock turns lower
Feb 24 BHC UPDATE 2-Under eye of Icahn, Bausch Health gives activist investor two board seats

Irritable bowel syndrome (IBS) is a group of symptoms—including abdominal pain and changes in the pattern of bowel movements without any evidence of underlying damage. These symptoms occur over a long time, often years. It has been classified into four main types depending on whether diarrhea is common, constipation is common, both are common, or neither occurs very often (IBS-D, IBS-C, IBS-M, or IBS-U respectively). IBS negatively affects quality of life and may result in missed school or work. Disorders such as anxiety, major depression, and chronic fatigue syndrome are common among people with IBS.The causes of IBS are not clear. Theories include combinations of gut–brain axis problems, gut motility disorders, pain sensitivity, infections including small intestinal bacterial overgrowth, neurotransmitters, genetic factors, and food sensitivity. Onset may be triggered by an intestinal infection, or stressful life event. IBS is a functional gastrointestinal disorder. Diagnosis is based on signs and symptoms in the absence of worrisome features. Worrisome features include onset at greater than 50 years of age, weight loss, blood in the stool, or a family history of inflammatory bowel disease. Other conditions that may present similarly include celiac disease, microscopic colitis, inflammatory bowel disease, bile acid malabsorption, and colon cancer.There is no known cure for IBS. Treatment is carried out to improve symptoms. This may include dietary changes, medication, probiotics, and counseling. Dietary measures include increasing soluble fiber intake, a gluten-free diet, or a short-term diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs). The medication loperamide may be used to help with diarrhea while laxatives may be used to help with constipation. Antidepressants may improve overall symptoms and pain. Patient education and a good doctor–patient relationship are an important part of care.About 10 to 15% of people in the developed world are believed to be affected by IBS. It is more common in South America and less common in Southeast Asia. It is twice as common in women as men and typically occurs before age 45. The condition appears to become less common with age. IBS does not affect life expectancy or lead to other serious diseases. The first description of the condition was in 1820 while the current term "irritable bowel syndrome" came into use in 1944.

More about Irritable Bowel Syndrome
Browse All Tags